Search peptides, terms, sources/
Research source · 2022

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension

About this source

Kind
Research
Design
Human clinical trial
Population
Subset of STEP 1 participants post-withdrawal
Primary or secondary
primary
Retraction status
None known
Date checked
14 August 2026

Limitations

Single extension study; not independently replicated.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.